...
首页> 外文期刊>Applied Catalysis, B. Environmental: An International Journal Devoted to Catalytic Science and Its Applications >Facile control of defect site density and particle size of UiO-66 for enhanced hydrolysis rates: insights into feasibility of Zr(IV)-based metal-organic framework (MOF) catalysts
【24h】

Facile control of defect site density and particle size of UiO-66 for enhanced hydrolysis rates: insights into feasibility of Zr(IV)-based metal-organic framework (MOF) catalysts

机译:容易控制UIO-66的缺陷位点和粒径,用于增强水解率:Zr(iv)基于金属 - 有机骨架(MOF)催化剂的可行性见解

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A catalytic hydrolysis rate of nerve agents can be a significant issue because of their severe toxicity which can lead to severe damage to human life. Regarding the issue, much effort has been given rise to the development of the various design of Zr(IV)-based MOF catalysts so that high catalytic performance. However, we still have feasibility issues. To this end, we turned our attention to develop the method for facile, scalable, and efficient synthesis of Zr(IV)-based MOFs (UiO-66) with high-performance hydrolysis by imparting enriched active sites to the catalysts, as well as to examine its feasibility using the combination of Ui0-66 with the organic bases including 4-ethylmorpholine (4-EM) and linear-/ branch-type polyethyleneimine (PEI). The modulated UiO-66 catalysts were synthesized by varying the total reaction concentration. The synthesized three different UiO-66 catalysts were characterized and then applied for hydrolysis rates of the methylparaoxon (MPO) nerve agent simulant. From these investigations, we found that the highest concentration led to the smallest particle size (ca. 100 nm) and highest defect density (1.8 per cluster), resulting in 3-times higher catalytic activity (0.548 s(-1)) in turnover frequency (TOF) relative to that of the uncontrolled UiO-66 (ca. 580 nm and 1.6 per cluster) (0.188 (-1)) which is prepared by the reported procedure. In addition, the reaction process significantly influenced on the catalytic activity of UiO-66, in which the simple change of the reagent mixing method led to a ca. 182-times difference in the catalytic activity for MPO hydrolysis despite using the same reagents including catalysts and bases. Importantly, we found that the reaction process-dependent catalytic activity of UiO-66 can be significantly associated with the chelation of Zr(IV) Lewis acidic active sites by base materials of 4-EM and PEI (Lewis base). Furthermore, the solid-state catalytic system based on the polymer composite of Ui0-66S/LPEI Ok on the cotton fabric was also examined for MPO hydrolysis at various relative humidity and temperature conditions to create actual atmosphere conditions, which gave the possibility for actual military applications such as protective suits and equipment. In addition, we schematically demonstrated the loss of active sites on Ui0-66 by chelation effects based on experimental and density functional theory (DFT)-derived computational simulation because it is highly correlated to the feasibility of Zr(IV)-based MOF catalysts for detoxification of nerve agents. In addition, we carefully propose a plausible reaction mechanism step on the nucleophilic attack by hydroxide group on the basis of the computational simulation.
机译:由于其严重的毒性,神经剂的催化水解率可能是一个重要的问题,这可能导致人类生命严重损害。关于问题,Zr(IV)的各种设计的发展,Zr(IV)的催化剂的各种设计,使得催化性能很大。但是,我们仍然有可行性问题。为此,我们注意到通过赋予催化剂的富集的活性位点,以及高性能水解,开发ZR(IV)基础的MOFS(UIO-66)的容易,可扩展和高效合成的方法,以及富含富含催化剂的方法,以及使用UI0-66的组合与有机碱的组合来检查其可行性,包括4-乙基丙酮(4-EM)和线性/分支型聚乙烯亚胺(PEI)。通过改变总反应浓度来合成调制的UIO-66催化剂。合成的三种不同的UIO-66催化剂的特征在于,然后施用于甲基苯并氧诺(MPO)神经剂模拟剂的水解速率。从这些调查中,我们发现,最高浓度导致最小的粒径(约100nm)和最高缺陷密度(每簇1.8),导致营业额增加3倍的催化活性(0.548秒(-1))频率(TOF)相对于不受控制的UIO-66(CA.580nm和每簇1.6)(0.188(-1)),由报道的程序制备。此外,反应过程对UIO-66的催化活性影响显着影响,其中试剂混合方法的简单变化LED为CA.尽管使用包括催化剂和碱的相同试剂,MPO水解的催化活性差异为182倍。重要的是,我们发现UIO-66的反应过程依赖性催化活性可以通过4-EM和PEI(Lewis Base)的基础材料与Zr(iv)Lewis酸性活性位点的螯合显着相关。此外,还在棉织物上基于UI0-66S / LPEI的聚合物复合物的固态催化系统,用于在各种相对湿度和温度条件下进行MPO水解,以产生实际的大气条件,这给了实际军事的可能性保护套装和设备等应用。此外,我们示意性地证明了通过基于实验和密度泛函理论(DFT)的计算模拟的螯合效应来抑制UI0-66上的活性位点,因为它与基于Zr(IV)的可行性高度相关的MOF催化剂神经药物的解毒。此外,我们在计算模拟的基础上仔细提出了氢氧化物组的亲核侵袭的合理反应机制步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号